(19)
(11) EP 1 023 068 A1

(12)

(43) Date of publication:
02.08.2000 Bulletin 2000/31

(21) Application number: 98930307.8

(22) Date of filing: 17.06.1998
(51) International Patent Classification (IPC)7A61K 31/445, A61K 31/505, C07D 211/18, C07D 239/34, C07D 491/08, C07D 487/04, C07D 401/12, C07D 411/12, C07D 413/12
(86) International application number:
PCT/US9812/567
(87) International publication number:
WO 9857/638 (23.12.1998 Gazette 1998/51)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 18.06.1997 US 50959 P
07.01.1998 GB 9800217

(71) Applicants:
  • MERCK & CO., INC.
    Rahway, New Jersey 07065 (US)
  • SYNAPTIC PHARMACEUTICAL CORPORATION
    Paramus,New Jersey 07662-1410 (US)

(72) Inventors:
  • PATANE, Michael, A.
    Rahway, NJ 07065 (US)
  • BOCK, Mark, G.
    Rahway, NJ 07065 (US)
  • NEWTON, Randall, C.
    Rahway, NJ 07065 (US)
  • LAGU, Bharat
    Paramus, NJ 07652 (US)

(74) Representative: Horgan, James Michael Frederic 
Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS